Skip to main content
Premium Trial:

Request an Annual Quote

Exonhit, BGI Complete Project to Shed Light on Gene Deregulation

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Exonhit and BGI today announced they have completed a project to expand Exonhit's SpliceArray platform to an additional "strategic preclinical animal model species."

BGI's next-generation sequencing technology was combined with SpliceArray resulting in a "new powerful combination [that] will facilitate the rapid discovery, development, and commercialization of the most relevant therapeutics, biomarkers, and molecular diagnostics," Matthew Pando, executive vice president of therapeutics at Exonhit, said in a statement.

The goal of the project, whose terms have not been disclosed, is to shed light on gene deregulation and to develop biomarkers and molecular diagnostics for complex diseases, Exonhit said.

SpliceArray is a microarray-based platform that incorporates a specific probe configuration and is designed to monitor each isoform of an RNA splicing event, Paris-based Exonhit said on its website. The Human Genome-wide SpliceArray monitors known and predicted RNA-splicing events in almost 21,000 genes.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more